Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges

被引：24

作者：

Vitorino, Carla ^{[1
,2
,3
]}

Silva, Soraia ^{[1
,2
]}

Bicker, Joana ^{[1
,2
]}

Falcao, Amilcar ^{[1
,2
,4
]}

Fortuna, Ana ^{[1
,2
,4
]}

机构：

[1] Univ Coimbra, Fac Pharm, Coimbra, Portugal

[2] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal

[3] Univ Coimbra, Coimbra Chem Ctr, Dept Chem, Coimbra, Portugal

[4] Univ Coimbra, Coimbra Inst Biomed Imaging & Translat Res, CIBIT ICNAS, Coimbra, Portugal

来源：

DRUG DISCOVERY TODAY | 2019年 / 24卷 / 09期

关键词：

DRUG-DELIVERY; INTRANASAL INSULIN; NEUROPEPTIDE-Y; DOUBLE-BLIND; ANXIETY; SYSTEM; NANOPARTICLES; ESKETAMINE; DISORDERS; COGNITION;

D O I：

10.1016/j.drudis.2019.06.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Why is nose-to-brain delivery considered to be a strategy that directly allows the access of antidepressants to the brain? In which circumstances can the intranasal pathway be applicable? Are there any requirements to follow? What triggers the antidepressant market? Which constraints are imposed during discovery programs? What opportunities can arise and what is their current status of development? Are they already translated into clinical practice? Which challenges are expected from recent development strategies? This review aims at providing a critical appraisal of nose-to-brain delivery of antidepressants, framed within a comprehensive analysis of drivers, restraints, opportunities and challenges.

引用

页码：1911 / 1923

页数：13

共 50 条

[41] Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders
Ong, Wei-Yi
Shalini, Suku-Maran
Costantino, Luca
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (37) : 4247 - 4256
[42] Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure
Dimiou, Savvas
Lopes, Rui M.
Kubajewska, Ilona
Mellor, Ryan D.
Schlosser, Corinna S.
Shet, Manjunath S.
Huang, Hugh
Akcan, Ozgur
Whiteside, Garth T.
Schatzlein, Andreas G.
Uchegbu, Ijeoma F.
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 618
[43] Nose-to-brain delivery of nano-engineered biomaterials for effective targeting to the brain
Kashif, Mehboob Ur Rehman
Sohail, Muhammad
Mahmood, Arshad
Shah, Syed Ahmed
Abbasi, Mudassir
Kousar, Mubeen
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2024,
[44] Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease
Passoni, Alice
Favagrossa, Monica
Colombo, Laura
Bagnati, Renzo
Gobbi, Marco
Diomede, Luisa
Birolini, Giulia
Di Paolo, Eleonora
Valenza, Marta
Cattaneo, Elena
Salmona, Mario
ACS CHEMICAL NEUROSCIENCE, 2020, 11 (03): : 367 - 372
[45] Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, David
Minko, Tamara
PHARMACEUTICS, 2021, 13 (12)
[46] Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway
Siva Ram Kiran Vaka
Sathyanarayana Narasimha Murthy
Anna Balaji
Michael A. Repka
Pharmaceutical Research, 2012, 29 : 441 - 447
[47] Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway
Vaka, Siva Ram Kiran
Murthy, Sathyanarayana Narasimha
Balaji, Anna
Repka, Michael A.
PHARMACEUTICAL RESEARCH, 2012, 29 (02) : 441 - 447
[48] Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management
Upadhaya, Prashant G.
Pulakkat, Sreeranjini
Patravale, Vandana B.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2020, 10 (04) : 1044 - 1056
[49] Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies
Boyuklieva, Radka
Zagorchev, Plamen
Pilicheva, Bissera
BIOMEDICINES, 2023, 11 (08)
[50] Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
Chen, Yingchong
Liu, Yuling
Xie, Jin
Zheng, Qin
Yue, Pengfei
Chen, Liru
Hu, Pengyi
Yang, Ming
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 10435 - 10451

← 1 2 3 4 5 →